# Erk3 deletion drives oxidative adaptations in skeletal muscle

**Authors:** Angel Loza-Valdes, Carlos Acosta-Gallo, Toufic Kassouf, Andrei Belykh, Małgorzata Stelmach, Dominika Malińska, Katia El Ghoz, Rabih El-Merahbi, Filip Dziaczkowski, Katarzyna Kolczyńska-Matysiak, Grzegorz Sumara

PMC · DOI: 10.1016/j.molmet.2026.102338 · Molecular Metabolism · 2026-02-24

## TL;DR

Deleting Erk3 in skeletal muscle boosts energy use and protects against obesity and diabetes by increasing mitochondria and shifting muscle fibers to a more oxidative type.

## Contribution

Erk3 is identified as a key regulator of oxidative adaptations in skeletal muscle under metabolic stress.

## Key findings

- Erk3 deletion in muscle protects mice from obesity and insulin resistance by increasing energy expenditure.
- Erk3 and Mk5 influence muscle metabolism through distinct molecular pathways.
- Deleting Erk3 or Mk5 enhances mitochondrial function and promotes oxidative fiber identity in myotubes.

## Abstract

Skeletal muscle plays a central role in whole-body energy expenditure and metabolic homeostasis, and improving its mitochondrial function and oxidative fiber profile is considered an effective strategy to counteract diet-induced metabolic impairments, although the molecular regulators of these adaptations are not yet fully understood. Erk3 has been implicated in myotube differentiation and in skeletal muscle adaptations to aerobic exercise; however, its potential role in skeletal muscle during diet-induced metabolic dysfunction remains to be determined.

In this study, we used mice with striated muscle-specific Erk3 deletion alongside in vitro cultured myotubes, integrating metabolic phenotyping, indirect calorimetry, multi-omics profiling, and analyses of muscle morphology and fiber-type composition.

Deletion of Erk3 in striated muscle protected mice from diet-induced obesity, glucose intolerance, and insulin resistance, accompanied by increased energy expenditure and elevated mitochondrial content. In cultured myotubes, silencing Erk3 or its putative interaction partner Mapkapk5 (Mk5) enhanced mitochondrial respiration and mitochondrial abundance, particularly under lipid overload. Global transcriptomic and proteomic analyses in myotubes deficient for either Erk3 or Mk5 revealed largely distinct molecular signatures for both kinases. However, consistent with increased oxidative respiration in the absence of Erk3 or Mk5, markers of oxidative fiber types were elevated while glycolic-fiber-specific proteins were diminished in the absence of one or the other kinase. Consistent with these findings, high-fat diet-fed Erk3-deficient mice showed fewer centrally located nuclei and were protected from the fiber-type remodeling associated with metabolic dysfunction.

Our study demonstrates that Erk3 is a key regulator of skeletal muscle oxidative remodeling and metabolic resilience. The deletion of Erk3 in muscles promotes energy expenditure in the myotubes by enhancing mitochondrial function and shifting fiber identity toward oxidative types. Thus, deletion of this kinase protects against high-fat diet–induced obesity, glucose intolerance, and insulin resistance.

Image 1

•Muscle-specific Erk3 deletion enhances energy expenditure and protects from diet-induced metabolic dysfunction.•Erk3 deletion increases mitochondrial function and oxidative fiber identity.•Erk3 and Mapkapk5 shape muscle metabolic programs through distinct pathways.

Muscle-specific Erk3 deletion enhances energy expenditure and protects from diet-induced metabolic dysfunction.

Erk3 deletion increases mitochondrial function and oxidative fiber identity.

Erk3 and Mapkapk5 shape muscle metabolic programs through distinct pathways.

## Linked entities

- **Genes:** MAPK6 (mitogen-activated protein kinase 6) [NCBI Gene 5597], MAPKAPK5 (MAPK activated protein kinase 5) [NCBI Gene 8550], MAPKAPK5 (MAPK activated protein kinase 5) [NCBI Gene 8550]
- **Diseases:** obesity (MONDO:0011122), glucose intolerance (MONDO:0001076)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Ckm (creatine kinase, muscle) [NCBI Gene 12715] {aka CPK-M, Ckmm, M-CK, MCK}, Slc2a4 (solute carrier family 2 (facilitated glucose transporter), member 4) [NCBI Gene 20528] {aka GT2, Glut-4, Glut4, twgy}, Des (desmin) [NCBI Gene 13346], MAPKAPK5 (MAPK activated protein kinase 5) [NCBI Gene 8550] {aka MAPKAP-K5, MK-5, MK5, NCFD, PRAK}, Atp5f1a (ATP synthase F1 subunit alpha) [NCBI Gene 11946] {aka Atp5a1, Atpm, D18Ertd206e, Mom2}, Mapkapk5 (MAP kinase-activated protein kinase 5) [NCBI Gene 17165] {aka MK5, PRAK}, MAPK6 (mitogen-activated protein kinase 6) [NCBI Gene 5597] {aka ERK3, HsT17250, PRKM6, p97MAPK}, Myh2 (myosin, heavy polypeptide 2, skeletal muscle, adult) [NCBI Gene 17882] {aka MHC2A, MyHC-2a, MyHC-IIa, Myh2a, Myhs-f, Myhs-f1}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, Ighg1 (immunoglobulin heavy constant gamma 1 (G1m marker)) [NCBI Gene 16017] {aka IgG1, Igh-4, VH7183}, PNPLA2 (patatin like domain 2, triacylglycerol lipase) [NCBI Gene 57104] {aka 1110001C14Rik, ATGL, FP17548, PEDF-R, TTS-2.2, TTS2}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Ighm (immunoglobulin heavy constant mu) [NCBI Gene 16019] {aka Igh-6, Igh-M, Igh6, Igm, TC1460681, muH}, Myod1 (myogenic differentiation 1) [NCBI Gene 17927] {aka MYF3, MyoD, Myod-1, bHLHc1}, Gm12551 (perilipin 2 pseudogene) [NCBI Gene 101055843], Foxo3 (forkhead box O3) [NCBI Gene 56484] {aka 1110048B16Rik, 2010203A17Rik, FKHRL1, Fkhr2, Foxo3a}, Ighg2b (immunoglobulin heavy constant gamma 2B) [NCBI Gene 16016] {aka IgG2b, Igh-3, gamma2b}, Myh4 (myosin, heavy polypeptide 4, skeletal muscle) [NCBI Gene 17884] {aka MHC2B, MM, MYH-2B, Minimsc, Minmus, MyHC-IIb}, Vcl (vinculin) [NCBI Gene 22330] {aka 9430097D22}, Myh7 (myosin, heavy polypeptide 7, cardiac muscle, beta) [NCBI Gene 140781] {aka B-MHC, MYH-beta/slow, MyHC-I, Myhc-b, Myhcb, beta-MHC}, FOXO1 (forkhead box O1) [NCBI Gene 2308] {aka FKH1, FKHR, FOXO1A}, Foxo1 (forkhead box O1) [NCBI Gene 56458] {aka Afxh, FKHR, Fkhr1, Foxo1a}, Mapk4 (mitogen-activated protein kinase 4) [NCBI Gene 225724] {aka A330097D03Rik, Erk3, Prkm4, p63Mapk}
- **Diseases:** fatigue (MESH:D005221), Bodyweight gain (MESH:D015430), obesity (MESH:D009765), mass (MESH:C536030), HFD (MESH:D004620), metabolic (MESH:D008659), mitochondrial biogenesis (MESH:D028361), muscle atrophy (MESH:D009133), inflammation (MESH:D007249), sarcopenia (MESH:D055948), hyperglycemia (MESH:D006943), metabolic disturbances (MESH:D024821), glucose homeostasis (MESH:D044882), impaired (MESH:D060825), muscle weakness (MESH:D018908), diabetes (MESH:D003920), hypertrophic (MESH:D002312), adiposity (MESH:D018205), glucose intolerance (MESH:D018149), Adenovirus infection (MESH:D000257), reduction in (MESH:D015431), insulin resistance (MESH:D007333), infection (MESH:D007239)
- **Chemicals:** peptides (MESH:D010455), TRIzol (MESH:C411644), water (MESH:D014867), poly-T (MESH:D011071), Blood glucose (MESH:D001786), FCCP (MESH:D002259), Alexa Fluor 555 (MESH:C000608607), SDS (MESH:D012967), TCEP (MESH:C080938), Oxygen (MESH:D010100), fat (MESH:D005223), methionine (MESH:D008715), OCT (MESH:C051883), acetonitrile (MESH:C032159), Triton X-100 (MESH:D017830), streptomycin (MESH:D013307), lactate (MESH:D019344), uracils (MESH:D014498), nitrogen (MESH:D009584), antimycin A (MESH:D000968), PA (MESH:D019308), cysteine (MESH:D003545), lipid (MESH:D008055), paraformaldehyde (MESH:C003043), ATP (MESH:D000255), CO2 (MESH:D002245), rotenone (MESH:D012402), L-glutamine (MESH:D005973), glucose (MESH:D005947), DAPI (MESH:C007293), oligomycin (MESH:D009840), poly(A) (MESH:D011061), eosin (MESH:D004801), lysine (MESH:D008239), Tween (MESH:D011136), PBS (MESH:D007854), PVDF (MESH:C024865), K (MESH:D011188), penicillin (MESH:D010406), hematoxylin (MESH:D006416), HEPES (MESH:D006531), DharmaFECT (-), crystal violet (MESH:D005840), CAA (MESH:C013874), H&amp;E (MESH:D006371), isopentane (MESH:C067038), carbohydrates (MESH:D002241), fatty acid (MESH:D005227), Alexa Fluor 488 (MESH:C000711379), hydroxylamine (MESH:D019811)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** T382E
- **Cell lines:** C2C12 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0188), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12969653/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12969653/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC12969653/full.md

---
Source: https://tomesphere.com/paper/PMC12969653